Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
HER2+ Metastatic Breast Cancer (MBC) Care in Second-Line Treatment and Beyond
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
HER2+ Metastatic Breast Cancer (MBC) Care in Second-Line Treatment and Beyond
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Best Practices for Drug-Drug Interactions (DDIs) Management for Oral COVID-19 Antivirals
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Treating Older Patients with HR+/HER2- Metastatic Breast Cancer (mBC): Best Practices for Their Assessment and Care
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Treating the Whole Patient: Considerations for Patients with HR+/HER2- Metastatic Breast Cancer (mBC) and Existing Comorbidities
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
Release Date:
Review Process: Pfizer Internal
Education Rare Disease USA
Closing the Gaps within Intestinal Ultrasound
Release Date:
Partner: International Bowel Ultrasound Group
Review Process: Expert Review Panel
Research Inflammation & Immunology All
Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
BOOST - Multiple Myeloma An Oncology Boosting Program
Release Date:
Review Process: Expert Review Panel
Translation:(link)
Quality Improvement Oncology Netherlands
Title
Grant Type
Focus Area
Country
Application Due Date
Pneumococcal Disease Prevention
Release Date:
Chronic Pain
Release Date:
Bacterial Infections
Release Date:
Pharmacy Pneumococcal Disease Prevention
Release Date:
Smoking Cessation
Release Date:
Non-Small Cell Lung Cancer
Release Date:
Cardiovascular Risk in Rheumatoid Arthritis
Release Date:
Opioid Pain
Release Date:
Adult Pneumococcal Disease Prevention
Release Date:
Prevention of Stroke in Women
Release Date:
Oncology Educational Needs Assessments
Release Date:
Extension Grant
Release Date: